Fresenius Dialysis Treatment Lawsuit

Contact A Lawyer

Have A Potential Case Reviewed By An Attorney

  • This field is for validation purposes and should be left unchanged.

Fresenius Medical Care may have withheld important information about the potential side effects of NaturaLyte and GranuFlo acid concentrate drugs for dialysis treatment, which may have caused thousands of people to suffer:

  • Cardiac Arrest
  • Heart Attack
  • Sudden Death

STATUS OF FRESENIUS DIALYSIS LAWSUITS: These lawsuits are no longer being reviewed after Fresenius agreed to a $250 million settlement agreement to resolve the litigation.


OVERVIEW: Granuflo dry acid concentrate and NaturaLyte liquid concentrate are used during dialysis treatment together with a bicarbonate buffer to help clean the blood for individuals suffering kidney or renal impairment.

These products are manufactured by Fresenius Medical Care, which operates thousands of dialysis clinics throughout the United States and also sells equipment and medications used at most other dialysis centers, including DaVita Dialysis Clinics, DCR, Renal Ventures and others.

Before 2012, individuals may have faced a serious risk of suffering a sudden heart attacks and cardiac arrest during dialysis treatment with Granuflo and NaturaLyte, due to Fresenius Medical Care’s failure to provide adequate warnings and instructions with their product.

Granuflo and NaturaLyte contain sodium acetate, which is converted into bicarbonate by the body during and shortly after dialysis treatment. However, the manufacturer failed to warn physicians that these products contain higher levels of acetate than most other dialysis treatment products, requiring physicians to carefully monitor and change bicarbonate buffers administered with Granuflo or NaturaLyte, to avoid a risk of cardiopulmonary arrest and sudden death from heart problems.

LAWSUITS OVER FRESENIUS DIALYSIS TREATMENTS: A number of families throughout the United States filed claims after their loved ones died or suffered a catastrophic heart injury during or within 48 hours after dialysis treatment.

According to allegations raised in Fresenius dialysis treatment lawsuits:

  • Fresenius Medical Care negligently manufactured and sold unreasonably defective products
  • Granuflo and NaturaLyte were insufficiently tested and unsafe as designed
  • Inadequate warnings and instructions were provided with Granuflo and NaturaLyte, which did not fully inform the medical community about the nature and extent of the risk of heart attack, cardiac arrest, sudden cardiac death and other health problems
  • Even after Fresenius Medical Care knew or should have known about the problems with Granuflo and NaturaLyte, they continued to sell the products and attempted to convert clinics to use of the products by offering pricing discounts and packaging Granuflo and NaturaLyte with other dialysis products
  • Fresenius Medical Care provided critical information about the risk of heart attacks and death from Granuflo and NaturaLyte to doctor’s at their own clinics before warning other dialysis centers that used their products
  • Information was withheld in an attempt to maintain Fresenius Medical Care’s market share and maximize profits, at the expense of the safety of dialysis patients receiving their products

FRESENIUS DIALYSIS TREATMENT PROBLEMS: According to an internal review of patients treated at Fresenius Medical Care clinics during 2010, there were at least 941 cases where patients suffered a sudden cardiopulmonary arrest at the dialysis center.

In November 2011, Fresenius Medical Care issued an internal memo to their own physicians warning about the potential concerns associated with Granuflo and NaturaLyte, and highlighting that bicarbonate buffers should be regularly monitored and adjusted to reduce the risk of heart attack, cardiac arrest and death. This same information was not provided to other clinics that used Granuflo and NaturaLyte.

In March 2012, after receiving an inquiry from the FDA about the internal memo, Fresenius Medical Care issued an alert to other dialysis clinics that may use their Granuflo or NatruaLyte products during hemodialysis treatment.

In May 2012, the FDA warned about the risk of hemodialysis dosing problems with NaturaLyte Liquid and Granuflo Acid Concentrate, indicating that these products can raise bicarbonate levels in patients going through dialysis treatments, causing a condition known as metabolic alkalosis, which can increase the risk of heart attack, cardiac arrest, stroke, low blood pressure and death.

In June 2012, it was reported that Fresenius dialysis problems have resulted in an FDA investigation, examining whether the manufacturer of Granuflo and NaturaLyte failed to adequately warn doctors that the products could cause heart attacks and other serious injuries during hemodialysis.

In February 2016, Fresenius proposed a $250 million settlement agreement that is expected to be accepted and funded by August 2016.


  1. Theresa Reply

    I ask my attorney for my decease files and I was asked ,what for. What should I do?

  2. Joe Reply

    The fact is no lawyer know when this is going to end and or when the payouts are going be disbursed. I am not trying to imply I know more than anyone else.I am just getting information from the court docket and trying to explain what they mean. The truth is no matter if your lawyer is one of the lead lawyers or on the steering Committee or even if you got them off of the television at this point none of them know anymore than the other. I believe It is nearing the end though. Recent court procedures below.

    Docket last updated: 67 minutes ago
    Monday, June 26, 2017
    1895 minutes Motion Hearing ~Util – Set Hearings Order on Motion for Extension of Time Mon 3:49 PM
    Clerk’s Notes for Motion Hearing held before Judge Douglas P. Woodlock: Hagens Berman to identify the legal issues in the Dial appeal by 7/10/2017. Hearing on Motion for Summary Judgment62 in 14cv10712 (Burkes) scheduled for 8/30/2017 at 2:30 p.m. Defendants to file a list of opt out cases that are subject to remand and a schedule for remaining discovery that would be necessary in the opt out cases by 7/10/2017; plaintiff to respond by 7/24/2017. Court DENIES without prejudice1889 PEC’s Motion to Revise CMO1 re Post Lone Pine Leadership, subject to renewal providing proposed language and/or modification of the CMO1. If motion is resubmitted, Court will address at the 8/30/2017 hearing. Counsel for Beverly Hansberry unavailable today to discuss35 Motion to Withdraw as Counsel. Court will conduct phone conference tomorrow to discuss the motion by phone. Court GRANTS75 Assented to Motion for Relief from Judgment in 13cv11144 (Patton). Court addresses the duplicative actions, 13cv10596 and 13cv11996 (Dennison), and Orders Hagens Berman to file its position on the duplicative actions no later than 7/10/2017. Court ORDERS the PEC to file a supplemental affidavit addressing the three additional plaintiffs (Roy, Weaver, Steinkircher) and the chronology of the extensions given for plaintiffs to opt in to the settlement. Court GRANTS1856 Plaintiffs’ Consolidated Motion to Extend Time to Comply with the Entry of Lone Pine Order, to the extent that plaintiffs shall determine no later than 7/28/2017, whether to opt in to the settlement or comply with the Lone Pine Order. (Court Reporter: Brenda Hancock at [email protected].) Associated Cases: 1:13-md-02428-DPW, 1:13-cv-10596-DPW, 1:13-cv-11996-DPW, 1:14-cv-10712-DPW, 1:14-cv-12871-DPW(Beatty, Barbara)

  3. Joe Reply

    Look people, I don’t try to give false information out. I don’t believe any lawyer knows anymore than any other lawyer. But I do know my lawyer did say after May 31st and into the summer and it looks like the last hearing to resolve everything is on August 30 that falls right in line with what my lawyer said “into the summer” and disbursements won’t start until the fall. Look I am not trying to be better than anyone. I am just telling the facts and those are the facts. You can believe them or not it makes no difference to me.

  4. Arthur Reply

    Laurie are you an Attorney? You sound like one. You mentioned that you have had clients who had tried to receive a third party loan against their claim. You make the most sense of anyone here including Joe. I have one question for you. I received a letter from my Attorneys giving me an update and they still say there are 12,000 claiments which I know have dwindled down to a mere few. Mainly the 24 hours of dying after the treatments and the proof of cardiac arrest had to take place and the levels of Granuflo in your system as well. How many claimants are still left? According to my Attorneys they have 200 but they have also joined with other firms to reach the level. And they said that none of their cases were sent back. They are the lead Attorneys in this case. Also back in the first part of may they read me a letter stating that once Fresenius approves the agreement they have 35 days to distribute the checks. Who knows if that’s going to happen.

  5. JohnB Reply

    What happen in Judge Woodlock’s court yesterday. He has a meeting with Fresenius et al. at 10AM.

  • Share Your Comments

  • Have Your Comments Reviewed by a Lawyer

    Provide additional contact information if you want an attorney to review your comments and contact you about a potential case. This information will not be published.
  • NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

  • This field is for validation purposes and should be left unchanged.